PRECISION MEDICINE 2018: ASSEMBLING THE PUZZLE
Tuesday, June 26, 2018
8:00 AM to 5:00 PM (EDT)
Joseph B. Martin Conference Center
Harvard Medical School
77 Avenue Louis Pasteur
Boston, MA 02115
Patients continue to inspire and drive us to the leading edge of precision medicine. Yet at perhaps the most exciting and promising focus of precision medicine—its application to oncology—precision seems to matter less than predicted even 5 years ago. On the one hand, therapies such as the immune modulating drugs have emerged that appear effective across dozens of different cancers, yet the discovery of “driver mutations” in individual cancers continues to influence drug development and clinical decision making. In this context, how can patients help drive optimal decision making and societal investments in effective treatment and prevention of cancer and other diseases?
Our keynote this year, Greg Simon, President of the Biden Cancer Initiative, is ideally placed to answer this question both from the perspective of his role in founding FasterCures, patient advocacy within the pharmaceutical industry, and as a cancer survivor. Science and clinical care do not exist in isolation, and thus our first panel will address the question, "How do we overcome the disconnect between Patients, Clinicians, Insurers & Educators?" The panel includes leading representatives from payors, investors, data-driven oncology companies and media.
The question of patient leadership in precision medicine will be further explored in our second panel featuring citizen scientists, professional scientists who are parents of children requiring precision medicine therapies, as well as representatives of precision medicine companies.
Our third panel, composed of luminaries in technology and data science, will explore how digital technologies can help us complement molecular characterizations for further precision and to implement new precision medicine clinical workflows. Paul Varghese, alumni of our program, is a member of this panel.
Our closing keynote will be delivered by Jeremy Levin, whose career trajectory from successive leadership positions at large pharmaceutical companies to leading his own rare disease precision medicine company might presage a tectonic shift in the life science industry.
Visit the Department of Biomedical Informatics website for conference details and agenda.